Stock Agreements in the Pharmaceuticals Industry

1,826 Contracts & Agreements

Browse by Company

Acasti Pharma Inc. (4 contracts)
Accelerated Pharma, Inc. (1)
ACELRX PHARMACEUTICALS INC (9)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (4)
Acreage Holdings, Inc. (6)
ACURA PHARMACEUTICALS, INC (8)
Adamis Pharmaceuticals Corp (19)
ADIAL PHARMACEUTICALS, INC. (6)
Aegerion Pharmaceuticals, Inc. (18)
AEOLUS PHARMACEUTICALS, INC. (7)
AEON Biopharma, Inc. (1)
AERIE PHARMACEUTICALS INC (18)
Aerpio Pharmaceuticals, Inc. (6)
AGILE THERAPEUTICS INC (7)
Akers Biosciences, Inc. (6)
AKESIS PHARMACEUTICALS, INC. (10)
Akorn (15)
ALDER BIOPHARMACEUTICALS INC (7)
Alexza Pharmaceuticals Inc. (11)
ALGORX PHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (8)
Allergan, plc (1)
ALSERES PHARMACEUTICALS INC (15)
Altus Pharmaceuticals Inc. (9)
Amag Pharmaceuticals (36)
Amphastar Pharma (4)
Ampio Pharmaceuticals, Inc. (8)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (2)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (3)
ANADYS PHARMACEUTICALS INC (2)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (4)
ANGIOTECH PHARMACEUTICALS INC (3)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (6)
APP Pharmaceuticals, Inc. (1)
Applied BioSciences Corp. (3)
APRICUS BIOSCIENCES, INC. (9)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (5)
Aralez Pharmaceuticals Inc. (5)
ARIAD PHARMACEUTICALS INC (13)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
Artemis Therapeutics, Inc. (9)
ARVINAS, INC. (4)
Assertio Therapeutics, Inc (13)
Astex Pharmaceuticals, Inc (2)
ATAI Life Sciences B.V. (9)
Atea Pharmaceuticals, Inc. (5)
Athira Pharma, Inc. (4)
Auspex Pharmaceuticals, Inc. (5)
AUXILIUM PHARMACEUTICALS INC (14)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (1)
AVANIR PHARMACEUTICALS, INC. (5)
AVENUE THERAPEUTICS, INC. (2)
AXIM BIOTECHNOLOGIES, INC. (6)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (5)
Barrel Energy Inc. (1)
Baudax Bio, Inc. (3)
Bausch Health Companies Inc. (8)
BENTLEY PHARMACEUTICALS INC (1)
Bespoke Extracts, Inc. (2)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (10)
Biofrontera Inc. (3)
BioNumerik Pharmaceuticals, Inc. (8)
BioPharmX Corp (9)
Blue Water Acquisition Corp. (5)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (9)
Braeburn Pharmaceuticals, Inc. (1)
Bright Green Corp (1)
Bristol-Myers Squibb (8)
Canbiola, Inc. (9)
Cancer Prevention Pharmaceuticals, Inc. (6)
CANNAPHARMARX, INC. (1)
CANNAPOWDER, INC. (1)
Canopy Growth Corp (8)
Cara Therapeutics, Inc. (2)
CARDAX, INC. (6)
CASSAVA SCIENCES INC (4)
Catalent Inc (16)
Celator Pharmaceuticals Inc (2)
CELGENE CORP (1)
Cerecor Inc. (6)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (3)
CHINA PHARMA HOLDINGS, INC. (1)
China Yongxin Pharmaceuticals Inc. (1)
CinCor Pharma, Inc. (3)
Cingulate Inc. (5)
Citius Pharmaceuticals, Inc. (4)
Clearside Biomedical, Inc. (2)
Clever Leaves Holdings Inc. (4)
CLS Holdings USA, Inc. (2)
CNS Pharmaceuticals, Inc. (2)
Cocrystal Pharma, Inc. (6)
COGNITION THERAPEUTICS INC (5)
COLLAGENEX PHARMACEUTICALS INC (2)
COLLEGIUM PHARMACEUTICAL, INC (8)
CoLucid Pharmaceuticals, Inc. (3)
Columbia Care Inc. (3)
Context Therapeutics Inc. (1)
ContraVir Pharmaceuticals, Inc. (2)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (3)
CPEX Pharmaceuticals, Inc. (4)
Cronos Group Inc. (6)
CUBIST PHARMACEUTICALS INC (7)
CUMBERLAND PHARMACEUTICALS INC (6)
Cure Pharmaceutical Holding Corp. (2)
CymaBay Therapeutics, Inc. (3)
Cyteir Therapeutics, Inc. (2)
Dermata Therapeutics, Inc. (2)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (2)
DURECT CORP (11)
Edgewise Therapeutics, Inc. (4)
Egalet Corp (8)
Elanco Animal Health Inc (11)
Eleison Pharmaceuticals Inc (1)
ELITE PHARMACEUTICALS INC (6)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (12)
ENCYSIVE PHARMACEUTICALS INC (7)
Endo International plc (1)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (4)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (3)
Evolus, Inc. (6)
Exactus, Inc. (11)
EYEGATE PHARMACEUTICALS INC (4)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (9)
EYETECH PHARMACEUTICALS INC (6)
FRONTIER OILFIELD SERVICES INC (3)
Fulcrum Therapeutics, Inc. (3)
GENAISSANCE PHARMACEUTICALS INC (5)
GFR PHARMACEUTICALS INC (1)
GRAYBUG VISION, INC. (6)
GREEN HYGIENICS HOLDINGS INC. (2)
GridIron BioNutrients, Inc. (2)
Harmony Biosciences Holdings, Inc. (4)
HARROW HEALTH, INC. (10)
Haymaker Acquisition Corp. III (4)
HERATSI PHARMACEUTICALS (1)
Horizon Pharma plc (6)
Hoth Therapeutics, Inc. (3)
IDENIX PHARMACEUTICALS INC (5)
Ikena Oncology, Inc. (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (10)
INSPIRE PHARMACEUTICALS INC (10)
IntelGenx Technologies Corp. (4)
Intersect ENT, Inc. (4)
Intra-Cellular Therapies, Inc. (2)
ISTA PHARMACEUTICALS INC (6)
Jaguar Health, Inc. (18)
JAVELIN PHARMACEUTICALS, INC (3)
Jazz Pharmaceuticals plc (37)
Johnson & Johnson (5)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (3)
Jushi Holdings Inc. (7)
Kala Pharmaceuticals, Inc. (8)
Kaleido Biosciences, Inc. (2)
Kannalife Inc (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (2)
Landos Biopharma, Inc. (2)
Lannett Company, Inc. (4)
Lev Pharmaceuticals Inc (2)
Level Brands, Inc. (1)
Lexaria Bioscience Corp. (16)
Lilly (Eli) & Co. (37)
LIPELLA PHARMACEUTICALS INC (3)
Lipocine Inc. (2)
Liquidia Corp (6)
Liquidia Technologies Inc (2)
Longboard Pharmaceuticals, Inc. (3)
Lyra Therapeutics, Inc. (4)
Mallinckrodt (4)
MAP Pharmaceuticals, Inc. (6)
Marijuana Co of America, Inc. (2)
MARINUS PHARMACEUTICALS INC (3)
MAXIM PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (10)
MEMORY PHARMACEUTICALS CORP (4)
Menlo Therapeutics Inc. (3)
Merck (2)
MICROCHANNEL TECHNOLOGIES CORP (7)
MiddleBrook Pharmaceuticals, Inc. (4)
Milestone Pharmaceuticals Inc. (3)
Mind Medicine (MindMed) Inc. (3)
MJ Holdings, Inc. (4)
Molecular Insight Pharmaceuticals, Inc. (6)
MYnd Analytics, Inc. (12)
MyoKardia Inc (3)
Mystic Holdings Inc. (1)
Nabriva Therapeutics plc (1)
NAREK PHARMACEUTICALS (1)
NEKTAR THERAPEUTICS (10)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (12)
NewBridge Global Ventures, Inc. (8)
NGM BIOPHARMACEUTICALS INC (4)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (8)
NOVEN PHARMACEUTICALS INC (7)
NPS PHARMACEUTICALS INC (13)
NUCRYST Pharmaceuticals Corp. (2)
OCULAR THERAPEUTIX, INC (7)
Odonate Therapeutics, Inc. (6)
OMEROS CORP (6)
Omthera Pharmaceuticals, Inc. (3)
OncoMed Pharmaceuticals Inc (2)
Onconova Therapeutics, Inc. (5)
ONYX PHARMACEUTICALS INC (2)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (3)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (8)
Organon & Co. (1)
OSI PHARMACEUTICALS INC (9)
OTONOMY, INC. (1)
Pacira Pharmaceuticals, Inc. (9)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (7)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (1)
PENWEST PHARMACEUTICALS CO (3)
Perrigo (4)
Petros Pharmaceuticals, Inc. (3)
Pfizer (7)
PHARMOS CORP (1)
Phathom Pharmaceuticals, Inc. (3)
Phibro Animal Health Corporation (1)
Planet 13 Holdings Inc. (1)
PLAYERS NETWORK (10)
PLIANT THERAPEUTICS, INC. (2)
PLx Pharma Inc. (3)
PONIARD PHARMACEUTICALS, INC. (4)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (9)
Prestige Brands Holdings Inc (3)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (5)
PROTEO INC (7)
PROVECTUS BIOPHARMACEUTICALS, INC. (2)
Provention Bio, Inc. (2)
Pulmatrix, Inc. (3)
QUANTA INC (2)
QUARK PHARMACEUTICALS INC (18)
QUATRX PHARMACEUTICALS CO (3)
QUESTCOR PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (4)
RADIENT PHARMACEUTICALS Corp (8)
Rain Therapeutics Inc. (5)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (9)
Recro Pharma, Inc. (15)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (7)
RespireRx Pharmaceuticals Inc. (22)
resTORbio, Inc. (7)
Revance Therapeutics, Inc. (9)
Rib-X Pharmaceuticals, Inc. (4)
ROCK CREEK PHARMACEUTICALS, INC. (9)
Roivant Sciences Ltd. (2)
SALIX PHARMACEUTICALS LTD (7)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (9)
SCICLONE PHARMACEUTICALS INC (10)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (2)
SCYNEXIS INC (16)
SenesTech, Inc. (8)
Sienna Biopharmaceuticals, Inc. (1)
Sirtris Pharmaceuticals, Inc. (5)
Sonoma Pharmaceuticals, Inc. (12)
Strongbridge Biopharma plc (6)
Sucampo Pharmaceuticals, Inc. (3)
SUNWIN STEVIA INTERNATIONAL, INC. (5)
Supernus Pharmaceuticals, Inc. (5)
SYNERGY PHARMACEUTICALS, INC. (4)
Synovics Pharmaceuticals (2)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (3)
TAURIGA SCIENCES, INC. (4)
Tenzing Acquisition Corp. (1)
Terns Pharmaceuticals, Inc. (4)
Terra Tech Corp. (24)
TETRAPHASE PHARMACEUTICALS INC (4)
TFF Pharmaceuticals, Inc. (2)
The Medicines Company (2)
TherapeuticsMD, Inc. (4)
Theseus Pharmaceuticals, Inc. (3)
TITAN PHARMACEUTICALS INC (11)
Trevi Therapeutics, Inc. (2)
Tribute Pharmaceuticals Canada Inc. (2)
Tricida, Inc. (7)
Trulieve Cannabis Corp. (5)
Urigen Pharmaceuticals, Inc. (1)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (16)
Ventyx Biosciences, Inc. (5)
Verano Holdings Corp. (1)
VERBENA PHARMACEUTICALS INC (1)
Verrica Pharmaceuticals Inc. (3)
VIA Pharmaceuticals, Inc. (9)
Viamet Pharmaceuticals Holdings LLC (1)
VICURON PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (11)
Vireo Health International, Inc. (10)
Virpax Pharmaceuticals, Inc. (4)
Vitae Pharmaceuticals, Inc (6)
Vitality Biopharma, Inc. (4)
VIVUS INC (6)
WEED, INC. (2)
XANODYNE PHARMACEUTICALS INC (3)
XERIS PHARMACEUTICALS INC (2)
Zoetis (9)
ZOGENIX, INC. (4)
Zomedica Pharmaceuticals Corp. (3)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Goodness Growth Holdings, Inc. Non-Plan Restricted Stock Unit Agreement for Amber Shimpa, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Statutory Stock Option Agreement for Amber Shimpa, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Plan Restricted Stock Unit Agreement for Patrick Peters, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Statutory Stock Option Agreement for Patrick Peters, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Statutory Stock Option Agreement for John Heller (1,314,941 options), dated June 7, 2023 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Statutory Stock Option Agreement for John Heller (287,888 options), dated June 7, 2023 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Plan Restricted Stock Unit Agreement for Kyle Kingsley, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Statutory Stock Option Agreement for Kyle Kingsley, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Goodness Growth Holdings, Inc. Non-Plan Stock Option Agreement for Joshua Rosen, dated December 14, 2022 (Vireo Health International, Inc., Filed With SEC on April 1, 2024)
Description of Registrants Common Stock (GRAYBUG VISION, INC., Filed With SEC on March 28, 2024)
Stock Purchase Agreement, by and among Clever Leaves Holdings Inc., NSUS Holdings, Inc. and KAC Investments LLC, dated March 21, 2024 (Clever Leaves Holdings Inc., Filed With SEC on March 27, 2024)
Description of Capital Stock of Medicine Man Technologies, Inc (Medicine Man Technologies, Inc., Filed With SEC on March 27, 2024)
Form of Stock Purchase Agreement dated March 15, 2024 (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on March 21, 2024)
Affiliate Stock Purchase Agreement, dated as of March 13, 2024, by and between the Company and Michael Chancellor (LIPELLA PHARMACEUTICALS INC, Filed With SEC on March 15, 2024)
Affiliate Stock Purchase Agreement, dated as of March 13, 2024, by and between the Company and Jonathan Kaufman (LIPELLA PHARMACEUTICALS INC, Filed With SEC on March 15, 2024)
2020 Employee Stock Purchase Plan (IMARA Inc., Filed With SEC on March 14, 2024)
Description of Registrant's Capital Stock (Aerpio Pharmaceuticals, Inc., Filed With SEC on March 13, 2024)
Description of Cumberland Pharmaceutical's Common Stock (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on March 13, 2024)
Form of Stock Option Award for Inducement Grants to executive officer pursuant to the 2023 LTIP (EyePoint Pharmaceuticals, Inc., Filed With SEC on March 8, 2024)
Form of Stock Purchase Agreement, dated March 6, 2024, by and among the Company and the Purchasers (Ventyx Biosciences, Inc., Filed With SEC on March 7, 2024)
Amendment to Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation (Evolus, Inc., Filed With SEC on March 7, 2024)
Stock Purchase Agreement, dated as of September 30, 2014, by and between Strathspey Crown Holdings, LLC and ALPHAEON Corporation (Evolus, Inc., Filed With SEC on March 7, 2024)
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
Specimen Certificate Evidencing Shares of Common Stock (Pacira Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
Description of Capital Stock of Mind Medicine (MindMed) Inc (Mind Medicine (MindMed) Inc., Filed With SEC on February 28, 2024)
Amended and Restated 2007 Employee Stock Purchase Plan (approved November 1, 2023) (Jazz Pharmaceuticals plc, Filed With SEC on February 28, 2024)
Description of Capital Stock (Athira Pharma, Inc., Filed With SEC on February 22, 2024)
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (Lilly (Eli) & Co., Filed With SEC on February 21, 2024)
Form of Relative Value Award under the 2002 Lilly Stock Plan (Lilly (Eli) & Co., Filed With SEC on February 21, 2024)
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (Lilly (Eli) & Co., Filed With SEC on February 21, 2024)
Description of the Company's Common Stock (Lilly (Eli) & Co., Filed With SEC on February 21, 2024)
Form of Restricted Stock Unit Agreement under the 2024 Equity Inducement Plan (ALIMERA SCIENCES INC, Filed With SEC on February 9, 2024)
Form of Stock Option Agreement under the 2024 Equity Inducement Plan (ALIMERA SCIENCES INC, Filed With SEC on February 9, 2024)
Form of Amendment to Common Stock Purchase Warrants (CNS Pharmaceuticals, Inc., Filed With SEC on February 2, 2024)
Stock Purchase Agreement, dated January 22, 2024, by and between Planet 13 Holdings Inc. and SGW FL Enterprises, LLC (Planet 13 Holdings Inc., Filed With SEC on January 22, 2024)
Goodness Growth Holdings, Inc. Nonstatutory Stock Option Agreement dated December 21, 2023 (Vireo Health International, Inc., Filed With SEC on January 9, 2024)
Common Stock Purchase Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser (Liquidia Corp, Filed With SEC on January 8, 2024)
Inducement Stock Option Agreement, dated as of January 2, 2024, by and between Alimera Sciences, Inc. and Elliot Maltz (Non-Plan Inducement Award) (ALIMERA SCIENCES INC, Filed With SEC on January 4, 2024)
Inducement Stock Option Agreement, dated as of December 11, 2023, by and between Alimera Sciences, Inc. and Todd Wood (Non-Plan Inducement Award) (ALIMERA SCIENCES INC, Filed With SEC on December 12, 2023)